Tuesday, 11 June 2024

Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefits

As the F.D.A. considers a new Alzheimer’s medication, we asked experts how the rollout of a similar drug has gone.

from NYT > Top Stories https://ift.tt/vlsGTnH
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Adam O’Neal Resigns as Washington Post Opinion Editor

Adam O’Neal inherited a mandate from the paper’s owner, Jeff Bezos, to shift toward “personal liberties and free markets.” from NYT > T...